Advocacy Actions

2020-11-06 > Beijing

Advocacy Letter on Medical Device Registration Confidentiality Issues

On 06 November, the medical device sector sent an advocacy letter to the National Medical Products Administration on the medical device registration confidentiality issues.

Read more
2020-10-26 > Beijing

Teleconference with the European Commission deputy head of the medical devices and health tech assessment unit of DG SANTE

Teleconference with Deputy Head of the Medical Devices and Health Technology Assessment Unit of DG SANTE, getting his supports to the Second Medical Device Forum

Read more
2020-10-19 > Beijing

Comments on the CMDE's Public Consultation on the Technical Review Guideline on the Medical Device Cybersecurity (Second Draft)

On 19th October, the medical device sector of the European Chamber sent comments on the Technical Review Guideline on the Medical Device Cybersecurity (Second Draft) to the Centre for Medical Device Evaluation.

Read more
2020-09-16 > Beijing

Advocacy Letter to the Ministry of Science and Technology on Human Genetic Resources Management

On 16 September, the medical device sector sent an advocacy letter to the Ministry of Science and Technology on human genetic resources management.

Read more
2020-09-10 > Beijing

Advocacy Letter to the Center for Medical Device Evaluation on the Shelf Life Issues

On 11 September, the medical device sector sent an advocacy letter to the Center for Medical Device Evaluation re shelf-life issue.

Read more
2020-08-31 > Beijing

Submitted comments on the CMDE’s Public Consultation on the New and Revised Catalogue of Medical Devices Exempt From Clinical Trials (2020) (Draft for Comments) and the New and Revised Catalogue of In-vitro Diagnostic Reagent Exempt From Clinical Trails (

On 31st August, the medical device sector submitted comments on the Center for Medical Device Evaluation’s Public Consultation on the New and Revised Catalogue of Medical Devices Exempt from Clinical Trials (2020) (Draft for Comments) and the New and Revised Catalogue of In-vitro Diagnostic Reagent Exempt From Clinical Trails (2020) (Draft for Comments).

Read more
2020-08-26 > Beijing

Seminar with CMDE contributing the final draft of the Guideline for Technical Review of Human Factors Design of Medical Devices

Seminar with the CMDE contributing the final draft of the Guideline for Technical Review of Human Factors Design of Medical Devices, which will be revised for submission to NMPA for final approval

Read more
2020-08-18 > Beijing

Debrief “Buy China” issue updates in 2020 to the EU Delegation and the European Commission Trade Section

On 18 August, the medical device sector debriefed the "Buy China" updates in 2020 to the EU Delegation and shared with COCIR and updated it to the European Commission Trade Section.

Read more
2020-08-11 > Beijing

Sent the Review Report of the Center for Medical Device Evaluation Reform to the National Medical Products Administration and the Center for Medical Device Evaluation

On 11 August, the medical device sector sent the review report of the Center for Medical Device Evaluation Reform to the National Medical Products Administration and the Center for Medical Device Evaluation.

Read more
2020-07-20 > Beijing

Advocacy Letter on the Periodic Risk Evaluation Report submitted to the Centre for Drug Re-evaluation

On 20 July, the medical device sector sent an advocacy letter to the Centre for Drug Re-evaluation re the implementation of Periodic Risk Evaluation Report.

Read more